Key result
Breastfeeding is linked to ~24% lower risk of childhood glucose metabolism disorders, but not maternal.
Why the study?
Many cardiometabolic outcomes related to breastfeeding remain understudied in mothers and children long term after delivery.
Does any breastfeeding improve maternal and child cardiometabolic outcomes 10-14 years after delivery in maternal-child dyads?
Cohort (n=4,685)
Yes
Does any breastfeeding improve maternal and child cardiometabolic outcomes 10-14 years after delivery in maternal-child dyads?
Answers are grounded in this paper and cite their sources.
Breastfeeding is associated with improved long-term cardiometabolic outcomes in offspring, including reduced risks of glucose metabolism disorders and adiposity, as well as reduced maternal dyslipidemia.
Background:Breastfeeding can improve long-term maternal and child cardiometabolic outcomes, but many of the cardiometabolic outcomes remain understudied. Objective:To examine the association between breastfeeding and maternal and child cardiometabolic outcomes 10–14 years after delivery. Study Design:A secondary analysis of the prospective Hyperglycemia and Adverse Pregnancy Outcome Follow-Up Study (2013–2016). The exposure was any breastfeeding. The primary outcomes were maternal and child disorders of glucose metabolism assessed separately and defined as one of the following: prediabetes (impaired fasting glucose [100–125 mg/dL] or impaired glucose tolerance [2-hour plasma glucose of 140–199 mg/dL]) or type 2 diabetes mellitus. Secondary outcomes included maternal and child hypertension and dyslipidemia (low-density lipoprotein ≥103 mg/dL, total cholesterol ≥200 mg/dL, or triglycerides ≥200 mg/dL), and child adiposity (body fat percentage >85th). Multivariate logistic regression was used to examine the association between breastfeeding and maternal and child cardiometabolic outcomes. Results:Of 4,685 assessed maternal–child dyads, 79.7% reported breastfeeding. The risk of maternal disorders of glucose metabolism did not differ by breastfeeding status (24.1% versus 24.5% with versus without breastfeeding, adjusted relative risk [aRR] 1.00, 95% confidence interval [CI] 0.88–1.14). The risk of childhood disorders of glucose metabolism was lower with breastfeeding (10.7% versus 13.7%, aRR: 0.76, 95% CI: 0.63–0.92). With regard to secondary outcomes, mothers who breastfed had a lower rate of dyslipidemia (29.4% versus 32.8%, aRR: 0.88, 95% CI: 0.80–0.98). Offspring that were breastfed had lower rates of child adiposity (13.6% versus 17.5%, aRR: 0.82, 95% CI: 0.70–0.96). There was no difference in the rate of maternal hypertension by breastfeeding status. In the subgroup of mothers with gestational diabetes, breastfeeding was associated with a lower risk of child hypertension (aRR: 0.66, 95% CI: 0.45–0.99) and a lower risk of child adiposity measured by skinfold sum > 85th percentile (aRR: 0.67, 95% CI: 0.49–0.92). Conclusions:In an international prospective cohort, breastfeeding was associated with a reduced risk of maternal hypercholesterolemia and disorders of glucose metabolism and adiposity in the offspring.
No takes yet. Share an insight, caveat, or question.
Cui et al. (2025) conducted a cohort in Cardiometabolic outcomes (n=4,685). Breastfeeding vs. No breastfeeding was evaluated on Childhood disorders of glucose metabolism (prediabetes or type 2 diabetes mellitus) (aRR 0.76, 95% CI 0.63-0.92). Breastfeeding was associated with a lower risk of childhood disorders of glucose metabolism but not maternal disorders of glucose metabolism.
Synapse has enriched 10 related papers. Consider them for comparative context: